Myelodysplastic Syndrome After Olaparib Treatment in Heavily Pretreated Ovarian Carcinoma. [electronic resource]
Producer: 20200205Description: e632-e633 p. digitalISSN:- 1536-3686
- Adult
- BRCA1 Protein -- genetics
- Carcinoma, Ovarian Epithelial -- genetics
- Chemotherapy, Adjuvant -- adverse effects
- Female
- Germ-Line Mutation
- Humans
- Myelodysplastic Syndromes -- blood
- Neoplasm Recurrence, Local -- drug therapy
- Ovarian Neoplasms -- genetics
- Ovariectomy
- Phthalazines -- adverse effects
- Piperazines -- adverse effects
- Poly(ADP-ribose) Polymerase Inhibitors -- adverse effects
No physical items for this record
Publication Type: Case Reports; Letter
There are no comments on this title.
Log in to your account to post a comment.